NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive: Similarly, other analyses with a group of myeloid neoplasms, including AML, chronic phase CML and blast phase CML, described that NF-κB is markedly active in CML blast crisis when compared to the chronic phase of the disease[71].